To ask the Scottish Executivewhat feedback it has had from (a) individual NHS boards, (b) the Difficult Decisions Short Life Working Group and (c) other stakeholders on the draft policy framework for the introduction and availability of new medicines in the NHS. In responding to the draft framework, the majority of responses from NHS boards and stakeholders welcomed the work being done to improve consistency in availability of new medicines across NHSScotland and acknowledged the complexity of the issues involved.